
    
      Bronchopulmonary dysplasia (BPD) is a chronic lung disease in which premature infants and it
      results in significant morbidity and mortality. PNEUMOSTEM is intended to prevent and treat
      BPD by modulating inflammation and repairing damaged lung tissue in premature infants through
      paracrine effects.
    
  